Multifunctional bilayer scaffold for dental pulp protection and sustained calcium hydroxide release for mineralized tissue regeneration
Abstract
Injury to the mineralized tissues that protect the dental pulp can lead to pulp exposure and inflammation, necessitating the use of biologically active materials capable of preserving pulp vitality. While current biomaterials such as mineral trioxide aggregate (MTA) are widely used in vital pulp therapy (VPT), their high cost, challenging handling, and lack of structural flexibility highlight the need for alternatives. Here, we introduce a multifunctional bilayer scaffold composed of a polycaprolactone (PCL) film and a PCL/poly(ethylene oxide) (PCL/PEO) blend loaded with calcium hydroxide (CH), designed to provide both cytoprotection and mineralized tissue regeneration. The scaffold features a compact PCL layer, acting as a barrier to protect the pulp from external cytotoxic agents, and a CH-loaded fibrillar PCL/PEO electrospun layer, aimed at promoting odontoblastic differentiation through sustained calcium ion release. The bilayer structure demonstrated mechanical stability and a degradation profile suitable for clinical application. The release mechanism relies on gradual fiber degradation and CH dissolution. In vitro, the fibrillar layer enhanced calcium ion release, supported dental pulp stem cell adhesion and viability, and stimulated mineralized matrix formation. The compact layer preserved cell viability even in the presence of glass ionomer cement. In vivo, the bilayer scaffold elicited a comparable inflammatory response and expression of dentinogenesis and…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.